Dr. Narayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Clinic Building B, Suite 1400
Atlanta, GA 30322Phone+1 404-778-4898Fax+1 404-778-4006
Summary
- Dr. Vikram Narayan specializes in the surgical treatment of urologic cancers.
Dr. Narayan received his MD degree from the University of Florida College of Medicine in 2013. His general surgery internship and urology residency were done at the University of Minnesota, after which he completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer in 2020. During his fellowship, Dr. Narayan completed a year of basic science research investigating novel therapeutics for urothelial cancers including intravesical gene therapy, immune-based treatment options, and the role of the urinary microbiome in bladder cancer treatment.
Dr. Narayan's current research interests concentrate on understanding the mechanisms that underlie bladder cancer treatment responses in order to improve patients' therapeutic options. He has led projects studying quality outcomes for patients being treated for urothelial cancer. Dr. Narayan additionally has an interest in methodologic research, and has published several peer-reviewed articles about the performance of clinical urologic research and the transparent reporting of randomized trials and systematic reviews.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2020
- University of MinnesotaResidency, Urology, 2014 - 2018
- University of MinnesotaResidency, Surgery, 2013 - 2014
- University of Florida College of MedicineClass of 2013
Certifications & Licensure
- GA State Medical License 2020 - 2026
- TX State Medical License 2017 - 2025
- American Board of Urology Urology
Publications & Presentations
PubMed
- 1212 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20 - 46 citationsA systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer.Marius Goldkuhle, Vikram M. Narayan, Aaron Weigl, Philipp Dahm, Nicole Skoetz
BMJ Open. 2018-03-01 - 190 citationsIntravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella
The Lancet. Oncology. 2021-01-01
Books/Book Chapters
Press Mentions
- Immune Cell Find Boosts Cancer Immunotherapy HopesOctober 26th, 2024
- Immune Cell Discovery Offers New Potential for Cancer ImmunotherapyOctober 25th, 2024
- New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec Presented at Society of Urologic Oncology Annual Meeting Adds More Evidence to Data Published in Lancet OncologyDecember 2nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: